Pediatrix Medical
337 hedge funds and large institutions have $4B invested in Pediatrix Medical in 2017 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 122 increasing their positions, 111 reducing their positions, and 48 closing their positions.
15% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 48
2% more funds holding
Funds holding: 332 → 337 (+5)
10% more repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 111
2.85% less ownership
Funds ownership: 102.06% → 99.21% (-2.9%)
23% less call options, than puts
Call options by funds: $3.38M | Put options by funds: $4.39M
30% less capital invested
Capital invested by funds: $5.73B → $4B (-$1.73B)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$212M |
| 2 |
BHG
Blue Harbour Group
Greenwich,
Connecticut
|
+$46.7M |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$34.2M |
| 4 |
JP Morgan Chase
New York
|
+$32.6M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$27.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$146M |
| 2 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$120M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$100M |
| 4 |
ClearBridge Investments
New York
|
-$93.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$67.8M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
376
Creative Planning
Overland Park,
Kansas
| – | -$84K | -1,385 | Closed |
|
|
FMA
377
FNY Managed Accounts
New York
| – | -$14K | -246 | Closed |
|
|
SPIA
378
Steward Partners Investment Advisory
New York
| – | -$12K | -205 | Closed |
|
|
AIM
379
Acrospire Investment Management
Chicago,
Illinois
| – | -$12K | -201 | Closed |
|
|
HR
380
Howe & Rusling
Rochester,
New York
| – | -$7K | -114 | Closed |
|
|
NA
381
NewEdge Advisors
New Orleans,
Louisiana
| – | -$4.68K | -81 | Closed |
|
|
BBHC
382
Brown Brothers Harriman & Co
New York
| – | -$5K | -80 | Closed |
|
|
GT
383
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$3K | -46 | Closed |
|
|
LF
384
Lee Financial
Dallas,
Texas
| – | -$2K | -39 | Closed |
|
385
AssetMark Inc
Concord,
California
| – | +$428 | +9 | New |
|
MD Hedge Fund Activity: Q3 2017 in Review
337 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2017, worth a combined $4B — down 30% from $5.73B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new MD positions and 48 closed out — a net gain of 7 holders — while 122 added to existing stakes and 111 trimmed.
The largest buyer was Credit Suisse, adding an estimated $212M. The largest seller was Victory Capital Management, exiting entirely with an estimated $146M sold.
- 337 institutional investors held Pediatrix Medical (MD) as of Q3 2017, up from 332 in Q2 2017.
- Funds reported $4B of Pediatrix Medical stock for Q3 2017, down 30% quarter-over-quarter.
- 55 funds opened new Pediatrix Medical positions in Q3 2017 and 48 closed out, a net change of +7 holders.
- The largest Pediatrix Medical buyer in Q3 2017 was Credit Suisse, an estimated $212M added.
- The largest Pediatrix Medical seller in Q3 2017 was Victory Capital Management, an estimated $146M sold.
Based on aggregated 13F filings for Q3 2017.